Regeneron (REGN) Q4 Earnings & Sales Beat, Eylea Sales Decline
Regeneron (REGN) tops earnings and sales estimates for the fourth quarter. However, sales of the lead drug Eylea decline year…
715,071$
1,88%
Echtzeit-Aktienkurs Regeneron Pharmaceuticals Inc.
Bid:
Ask:
Nachrichten zur Regeneron Pharmaceuticals Inc. Aktie
Regeneron (REGN) Q4 Earnings and Revenues Beat Estimates
Regeneron (REGN) delivered earnings and revenue surprises of 29.75% and 7.84%, respectively, for the quarter ended December 2022. Do the…
Regeneron posts Q4 beat as COVID therapy offsets Eylea impact
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Regeneron Pharma Q4 Profit Declines; Adj. Total Revenues Up 14%
WASHINGTON (dpa-AFX) - Regeneron Pharmaceuticals, Inc. (REGN) reported fourth-quarter adjusted profit per share of $12.56 compared to $23.42, prior year.…
Form 8-K REGENERON PHARMACEUTICAL For: Feb 03
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Regeneron Pharmaceuticals Q4 Profit Declines
WASHINGTON (dpa-AFX) - Regeneron Pharmaceuticals (REGN) released earnings for fourth quarter that decreased from last yearThe companys earnings came in…
UPDATE 1-Regeneron quarterly profit plunges as COVID drug sales dry up
...(Adds quarter details, background)
Feb 3 (Reuters) - Regeneron......…
Regeneron stock rallies after profit and revenue beat expectations by wide margins
Shares of Regeneron Pharmaceuticals Inc. REGN rallied 1.9% toward a two-month high in premarket trading Friday, after the biotechnology company…
CORRECTED-Regeneron quarterly profit drops 46%
...
in paragraph 2)
Feb 3 (Reuters) - Regeneron Pharmaceuticals Inc
reported......…
Regeneron quarterly profit drops 46%
...(Reuters) - Regeneron Pharmaceuticals Inc reported an about 46......…
Regeneron Pharmaceuticals reports Q4 earnings beat; initiates FY23 guidance
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Regeneron Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
TARRYTOWN, N.Y., Feb. 03, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced financial results for…
DAX: US-Arbeitsmarktdaten am Nachmittag, Sanofi, Regeneron, ThyssenKrupp, Verbio, Apple, Amazon und Alphabet im Fokus – das ist heute wichtig
Nach der Vortagesrally dürften es die Anleger am Freitag am deutschen Aktienmarkt zunächst langsamer angehen lassen. Der Broker IG taxierte…
Time to Buy Cigna or Regeneron Stock Before Earnings?
Among the Finance and Medical sector, Cigna (CI) and Regeneron Pharmaceuticals (REGN) are both leaders in their respective industries and…
Regeneron (REGN) Stock Moves -0.86%: What You Should Know
Regeneron (REGN) closed the most recent trading day at $736.46, moving -0.86% from the previous trading session....…
Insiderhandel: Aufsichtsrat verkauft Aktien von Regeneron Pharmaceuticals im Wert von 747$
Brown, Michael S. - Aufsichtsrat - Tag der Transaktion: 2023-01-27...…
Regeneron upgraded at Cowen on potential of high dose Eylea
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Sanofi, Regeneron Dupixent gets approval in EU for expanded use in eosinophilic esophagitis
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Why Regeneron (REGN) is Poised to Beat Earnings Estimates Again
Regeneron (REGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…
Regeneron (REGN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Regeneron (REGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.…
Regeneron Pharma: CHMP Adopts Positive Opinion For Dupixent
PARIS (dpa-AFX) - Regeneron Pharmaceuticals, Inc. (REGN) and Sanofi announced the European Medicines Agencys Committee for Medicinal Products for Human…
Sanofi, Regeneron Dupixent gets EMA panel nod to treat eczema in kids under 5
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Sanofi/Regeneron: Dupixent wins new stage of EU regulatory approval
...PARIS, Jan 27 (Reuters) - Healthcare companies Sanofi
and Regeneron......…
Decibel, Regeneron get UK regulator nod to start trial of hearing loss gene therapy
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Regeneron (REGN) Gains But Lags Market: What You Should Know
Regeneron (REGN) closed the most recent trading day at $729.91, moving +1.1% from the previous trading session....…
Regeneron Pharmaceuticals: Hochstufung
New York (www.aktiencheck.de) - Rating-Update:
Chris Schott, Analyst von J.P. Morgan Securities, stuft die Aktie von Regeneron Pharmaceuticals (ISIN: US75886F1075, WKN:…
Regeneron upgraded at JPMorgan on upcoming catalysts
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Annexin appoints Dr. Alain Thibault as Therapeutic Area Head of Oncology.
STOCKHOLM January 18, 2023
Annexin Pharmaceuticals AB (publ) announces that Dr. Thibault, a medical oncologist with extensive global experience leading…
Regeneron (REGN) Outpaces Stock Market Gains: What You Should Know
Regeneron (REGN) closed the most recent trading day at $714.57, moving +0.65% from the previous trading session....…
Biotech Stock Roundup: REGN Down on Eylea Data, CINC Surges on AZN Offer & More
Updates from Regeneron (REGN) and CinCor Pharma (CINC) are the key highlights from the biotech sector during the past week....…
Insiderhandel: Aufsichtsrat verkauft Aktien von Regeneron Pharmaceuticals im Wert von 2.293.720$
Brown, Michael S. - Aufsichtsrat - Tag der Transaktion: 2023-01-06...…
Regeneron Pharmaceuticals: Kaufempfehlung bestätigt
Minneapolis (www.aktiencheck.de) - Rating-Update:
Christopher Raymond, Analyst von Piper Sandler, stuft die Aktie von Regeneron Pharmaceuticals (ISIN: US75886F1075, WKN: 881535, Ticker-Symbol:…
Regeneron slips after $0.21 per share impact to Q4 2022 earnings
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Regeneron Stock Sinks on Disappointing Sales of Eylea Vaccine
Eylea, which is injected into the eye, is meant to treat conditions such as macular degeneration, macular edema, and diabetic retinopathy....…
2seventy Bio, Regeneron in Amended Collaboration >TSVT REGN
2seventy Bio, Regeneron in Amended Collaboration >TSVT REGN...…
Insiderhandel: EVP Commercial verkauft Aktien von Regeneron Pharmaceuticals im Wert von 794.046$
Mccourt, Marion - Vorstand - Tag der Transaktion: 2023-01-03...…
Sensei Biotherapeutics Enters Clinical Supply Agreement With Regeneron For Libtayo
WASHINGTON (dpa-AFX) - Sensei Biotherapeutics, Inc. (SNSE) announced a clinical supply agreement with Regeneron for its anti-PD1 therapy Libtayo. The…
Sensei Biotherapeutics Announces Clinical Supply Agreement with Regeneron for Phase 1/2 Clinical Trial Evaluating SNS-101, a Conditionally Active VISTA-blocking Antibody, in Combination with Libtayo® (cemiplimab) in Solid Tumors
BOSTON, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), an immuno-oncology company focused on the…
Regeneron to Report Fourth Quarter and Full Year 2022 Financial and Operating Results and Host Conference Call and Webcast on February 3, 2023
TARRYTOWN, N.Y., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will…
Antikörper-Mittel von Regeneron senkt Risiko einer Corona-Infektion
Frankfurt (Reuters) - Eine Antikörper-Therapie des US-Pharmakonzerns Regeneron hilft einer Studie zufolge auch bei der Vorbeugung gegen eine symptomatische Covid-19-Infektion.
Regeneron…
Regeneron - Tierstudie zeigt Wirksamkeit von Wirkstoffkombination
(Reuters) - Das US-Biotech-Unternehmen Regeneron Pharmaceuticals hat in einer Studie an Tieren die Wirksamkeit einer Antikörper-Kombination zur Behandlung von Coronavirus-Erkrankungen…